Mediators of Inflammation

Intravitreal Inflammation: From Benchside to Bedside


Publishing date
02 Nov 2012
Status
Published
Submission deadline
15 Jun 2012

Lead Editor

1Department of Ophthalmology, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia


Intravitreal Inflammation: From Benchside to Bedside

Description

Inflammation plays a major role in the formation and in the progression of several chorioretinal diseases. A variety of factors are then released into the vitreous cavity, which can be more easily accessed for diagnostic purposes. Advances in the analysis of vitreous humour samples have highlighted new biological mechanisms of long-known diseases, providing a new perspective for therapeutic strategies. The analysis of vitreous samples is also instrumental for the differential diagnosis of inflammatory versus infective or neoplastic diseases of the eye. We particularly take an interest in manuscripts that report relevance of vitreous samples analyses for improved diagnosis, prognosis, or monitoring of therapy. Potential topics include, but are not limited to:

  • Proteomic analyses of the vitreous humour
  • Profile of lipid and soluble factor in diabetic retinopathy
  • Vitreous mediators in retinal hypoxic disease
  • Mechanism of inflammation in age-related macular degeneration
  • Mediators of inflammation in proliferative vitreoretinal disease
  • Vitreous diagnosis in neoplastic disease
  • Vitreous tap analysis in the management of uveitis
  • Intravitreal devices in treatment of vitreous inflammation
  • Systemic treatment of vitreous inflammation

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/mi/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

Mediators of Inflammation
 Journal metrics
See full report
Acceptance rate14%
Submission to final decision136 days
Acceptance to publication27 days
CiteScore7.700
Journal Citation Indicator0.570
Impact Factor4.6
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.